PT Millennium Pharmacon International Tbk (IDX:SDPC)
Indonesia · Delayed Price · Currency is IDR 200.00
0.00 (0.00%)
Sep 2, 2026, 11:37 AM WIB
IDX:SDPC Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,298,329 | 4,109,810 | 3,916,864 | 3,363,518 | 3,200,833 | 2,988,849 |
Revenue Growth | 9.67% | 4.93% | 16.45% | 5.08% | 7.09% | 13.06% |
Gross Profit Gross Profit Growth | 372,081 | 360,458 | 331,861 | 289,819 | 266,897 | 237,036 |
Operating Income Operating Income Growth | 118,785 | 113,537 | 96,434 | 92,717 | 73,900 | 57,475 |
Net Income Net Income Growth | 41,286 | 38,469 | 16,929 | 33,088 | 24,464 | 9,571 |
Earnings Per Share EPS Growth | 32.41 | 30.20 | 13.29 | 25.97 | 19.20 | 7.51 |
EPS Growth | 125.29% | 127.24% | -48.84% | 35.25% | 155.60% | 241.30% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Devices Medical Devices Growth | 1,078,183 | 949,673 | 846,587 | 673,208 | 600,654 |
Non-Prescription Medicine Non-Prescription Medicine Growth | 143,452 | 205,937 | 195,443 | 205,085 | 289,734 |
Prescription Medicine Prescription Medicine Growth | 2,887,792 | 2,761,107 | 2,321,400 | 2,322,540 | 2,098,461 |
Others Others Growth | 382.5 | 147.58 | 87.13 | - | - |
Total Total Growth | 4,109,810 | 3,916,864 | 3,363,518 | 3,200,833 | 2,988,849 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 33,780 | 62,843 | 53,473 | 58,900 | 25,668 | 47,362 |
Total Debt Total Debt Growth | 947,970 | 809,802 | 846,522 | 710,336 | 622,302 | 516,727 |
Net Cash (Debt) Net Cash Growth | -914,190 | -746,959 | -793,049 | -651,436 | -596,633 | -469,365 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -717.57 | -586.31 | -622.49 | -511.33 | -468.32 | -368.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -125,895 | 88,096 | -125,451 | -91,653 | -109,947 | -18,176 |
Capital Expenditures CapEx Growth | -37,978 | -37,760 | -14,159 | -19,933 | -5,359 | -4,473 |
Free Cash Flow Free Cash Flow Growth | -163,874 | 50,336 | -139,609 | -111,587 | -115,306 | -22,649 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 8.66% | 8.77% | 8.47% | 8.62% | 8.34% | 7.93% |
Operating Margin | 2.76% | 2.76% | 2.46% | 2.76% | 2.31% | 1.92% |
Pretax Margin | 1.31% | 1.19% | 0.71% | 1.43% | 1.14% | 0.60% |
Profit Margin | 0.96% | 0.94% | 0.43% | 0.98% | 0.76% | 0.32% |
FCF Margin | -3.81% | 1.23% | -3.56% | -3.32% | -3.60% | -0.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.000 | - | 2.000 | 2.500 | 2.000 | 1.000 |
Dividend Per Share Growth | 50.00% | - | -20.00% | 25.00% | 100.00% | 100.00% |
Dividend Yield | 1.08% | - | 1.57% | 1.67% | 0.65% | 0.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.17 | 5.13 | 9.93 | 6.08 | 17.29 | 18.10 |
P/FCF Ratio | - | 3.92 | - | - | - | - |
PS Ratio | 0.06 | 0.05 | 0.04 | 0.06 | 0.13 | 0.06 |